Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
368.50    0.00 (0.00%)
Bid:
355.00
Ask:
0.00
Spread: 14.00 (3.944%)
Market Cap: £1.88b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

27 Jun 2025 15:00

RNS Number : 8122O
Caledonia Investments PLC
27 June 2025
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving one of its directors, Jamie Cayzer-Colvin.

 

On 25 June 2025, 16,186 Shares, as noted in the table below, were transferred to Mr Cayzer-Colvin under the Caledonia Investments 2011 Performance Share Scheme ("2011 PSS") and the Caledonia Investments 2020 Deferred Bonus Plan ("DBP") at nil cost. The Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"). 

 

Director

2011 PSS

DBP

J M B Cayzer-Colvin

11,520

4,666

 

On the same date, Mr Cayzer-Colvin sold:

 

· 7,630 Shares to the EST to meet the tax liability due; and

· 1,822 Shares to a member of the Cayzer family concert party.

 

Mr Cayzer-Colvin retained 6,734 Shares.

 

Following the above transactions, Mr Cayzer-Colvin's beneficial interests in the Company increased. 

 

Each of these transactions were conducted on-market in London. The Shares were sold to the EST and a member of the Cayzer family concert party at 3712.5p per Share.

 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

250,969

0.477%

Non-beneficial

203,754

0.387%

Performance share scheme awards

98,559

0.187%

Deferred bonus plan awards

1,488

0.003%

 

Further information required by the UK Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

27 June 2025

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Caledonia Investments 2011 Performance Share Scheme ("PSS") award

 

2. Exercise of Caledonia Investments 2020 Deferred Bonus Plan ("DBP") award

 

3. Partial sale of shares arising from PSS and DBP exercise to The Caledonia Investments plc Employee Share Trust ("EST")

 

4. Partial sale of shares to a member of the Cazyer family concert party

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS award

 

 

2. Exercise of DBP award

 

 

3. Partial sale of shares arising from PSS award and DBP award to the EST

4. Partial sale of shares to a member of the Cazyer family concert party

 

Price(s)

 

Volume(s)

£nil

 

 

11,520

£nil

 

 

4,666

£37.125

 

 

7,630

£37.125

 

 

1,822

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

25 June 2025

f)

 

Place of the transaction

 

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDLDGDDGUR
Date   Source Headline
6th Sep 202411:28 amRNSNet Asset Value(s)
2nd Sep 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSCaledonia acquires Direct Tyre Management
19th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20242:30 pmRNSNet Asset Value(s)
5th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTotal Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20245:31 pmRNSResult of AGM
15th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.